Omega-3 Recommendations Updated: High-Dose Icosapent Ethyl for High-Risk Patients
European Atherosclerosis Society has shared a post on LinkedIn:
“The recommendation for the use of omega 3 polyunsaturated fatty acids from 2019 has changed in the Focussed Update by now explicitly stating that only high-dose icosapent ethyl should be considered for high-risk or very high-risk patients with elevated triglyceride levels.
The rationale for this revision was the negative STRENGTH trial which failed to demonstrate benefit of a combined EPA and DHA preparation which is in contrast to the REDUCE-it trial which showed a reduction in cardiovascular events in high risk patients with TG levels of 1,5-5,6 mmol/L with icosapent ethyl which is a pure EPA compound.
Moreover there is a new recommendation for patients with severe hypertriglyceridaemia due to familial chylomicronaemia syndrome based on the results of the randomized placebo controlled APPROACH trial which showed a 77% decrease in TG levels and reduction of pancreatitis in FCS patients treated with Volanesorsen an antisense Oligoligonucleotide targeting apoC3.
This led to the recommendation that volenasoren should be considered in FCS patients with severe hypertriglyceridemia to lower triglyceride levels and reduce the risk of pancreatitis.”
Learn more here.
Discover more on Hemostasis Today.
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026
-
Jun 23, 2026, 16:48Khusboo Kumari: Laboratory Skills in Hematology